What XR Therapeutics does

XR Therapeutics is a UK-based digital therapeutics company, spun out of Newcastle University in July 2020, that delivers extended reality (XR) therapy combining immersive virtual reality simulations with Cognitive Behavioural Therapy (CBT) for the treatment of anxiety, phobias, PTSD, OCD, depression, and autism-related conditions. Its platform comprises a content library of over 70 therapist-controlled treatment scenes displayed on 82-inch screens or VR headsets and managed via a tablet or laptop interface, alongside the Boundless remote delivery platform launched in April 2024 that enables therapy to be conducted via telehealth. The company is regulated by the MHRA as a UKCA Class I Software as a Medical Device, holds DTAC certification for NHS clinical safety standards, and is backed by 9 years of clinical research from Newcastle University and the Cumbria, Northumberland, Tyne and Wear NHS Trust.

The company operates a hybrid B2B/B2C revenue model. B2B revenue comes from multi-year licensing and implementation contracts with NHS trusts (7 trusts, 1 ICB, and 3 charities disclosed), including a structured 6-8 week deployment process with co-design workshops, CPD UK-accredited therapist training, and ongoing support. B2C revenue comes from direct private patient bookings at £395 for an initial six-session course, with additional sessions at £70 each and PayPal instalment options. Distribution is achieved through direct enterprise field sales to NHS decision-makers, a self-serve website booking flow for private patients, and partnership channels with charities and corporate CSR programmes. The company has approximately 14-16 employees based in Gateshead, with CEO Billy Webber leading a team that includes clinical founders Dr Morag Maskey (CSO) and Professor Jeremy Parr (Director), CTO Shaun Allan, COO Penny Day, and Chief Clinical Officer Andy Morrow.

Name

XR Therapeutics

Legal name

XR Therapeutics LTD

Website

https://xrtherapeutics.co.uk

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

XR Therapeutics is a UK digital therapeutics company that combines immersive extended reality simulations with CBT to treat anxiety, phobias, and related conditions, serving NHS mental health trusts, charities, and private patients through in-person therapy suites and the Boundless remote platform.

Ownership category

akta.pro rank

Product category

Digital Mental Health Therapy Software

NAICS

Offices of Physicians, Mental Health Specialists (621112), Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Prepackaged Software (7372), Services-Health Services (8000)

akta.pro primary industry

Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)

Keywords

• Extended reality therapy
• Virtual reality mental health
• Digital therapeutics platform
• Immersive CBT software
• Anxiety phobia treatment

Headquarters

HQ city

Gateshead

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Others

Revenue model

1. Private Patient Treatment: Direct-to-consumer therapy sessions for private patients. Initial course of 6 sessions costs £395, with additional sessions at £70 each. First discovery session is free. Payment accepted via PayPal pay in 3 and pay later options. Health insurance accepted.
2. NHS/Healthcare Trust Licensing: B2B licensing model for NHS trusts and mental health organizations. Includes platform access, training, and ongoing support. Implementation involves co-design workshops, full training, and 6-8 week deployment timeline.
3. Corporate/Charity Partnerships: Partnerships with employers and charities to fund treatment for employees or beneficiaries, such as Jackson Hogg funding treatment for a child with autism.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels8 records

Core offering

XR Therapeutics provides immersive extended reality (XR) therapy that combines therapist-controlled virtual reality simulations with Cognitive Behavioural Therapy (CBT) to treat anxiety, phobias, PTSD, OCD, and depression. The offering is delivered via in-person Digitally Enhanced Therapy Suites (over 70 treatment scenes displayed on screens/VR headsets and controlled by a tablet) and through the Boundless remote telehealth platform, sold to NHS trusts and other healthcare organisations under licensing arrangements and directly to private patients as pay-per-course treatment.

Product overview

XR Therapeutics operates a unified XR-enhanced mental health therapy platform comprising two primary delivery modes: the core XR Therapy service (using immersive extended reality simulations combined with CBT) and the Boundless remote software platform (launched April 2024 for telehealth delivery). The in-person delivery uses Digitally Enhanced Therapy Suites (with over 70 treatment scenes and relaxation scenes displayed on 82-inch screens, controlled via tablet). Therapist Training and implementation support services enable NHS and private sector adoption. The company was spun out from Newcastle University in July 2020 after 9 years of clinical research.

Differentiator

Problem solved

Functional benefit

Brands

• Boundless: A remote therapy software platform enabling XR therapy to be delivered via video call, allowing patients to receive treatment from home or any location. Launched in April 2024, Boundless expands accessibility beyond in-person studio sessions.

Products and services

• Boundless Remote Therapy Platform Software platform launched in April 2024 that enables remote XR therapy delivery via telehealth, allowing patients to receive therapist-guided immersive exposure therapy from home or any location without visiting a studio.
• XR Therapy Service Core XR therapy service combining immersive extended reality simulations with evidence-based CBT. Therapist-controlled digital simulations of real-world anxiety-triggering scenarios are used to treat anxiety, phobias, PTSD, depression, OCD, and autism-related conditions in adults and children.
• Digitally Enhanced Therapy Suite In-person therapy delivery system comprising an 82-inch TV displaying immersive scenes, a tablet/laptop controlling the simulations, and CPD-accredited training for therapists, installed in NHS trusts, charities, and hospitals.
• CPD-Accredited Therapist Training Programme CPD UK-accredited training programme that teaches therapists to deliver XR therapy sessions, including in-person training by the XRT clinical team, an e-learning platform, and patient/family communication support.

Quantifiable outcome

• 94% positive outcomes, 71% reliable recovery rate
• +6 more outcomes

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• South West London and St George's Mental Health NHS TrustcoreStrategic or Co-development Partner · 1 September 2025Partnership announced to provide cutting-edge mental health treatment to young people in south west London. XR therapy will be used to digitally simulate scenarios linked to anxieties and fears, used alongside CBT techniques. CAMHS services in Kingston, Merton, Richmond, Sutton and Wandsworth will have access to this technology.
• Newcastle UniversitycoreTechnology or IntegrationXR Therapeutics spun out from Newcastle University after a decade of clinical research. The company was founded by Dr Morag Maskey and Professor Jeremy Parr based on their research at the university. The technology is built on 9 years of clinical research from Newcastle University and Cumbria Northumberland Tyne and Wear NHS Trust.
• Cumbria Northumberland Tyne and Wear NHS TrustcoreTechnology or IntegrationClinical research partner for the development of XR therapy technology. Treatment scenes built from research conducted with this NHS trust alongside Newcastle University.
• Sheffield Children's NHS Foundation TrustcoreStrategic or Co-development PartnerNHS trust partner using XR therapy treatment. Features prominently in podcast discussion with Katheryn from Sheffield Children's NHS Foundation Trust about how immersive technology creates faster, more effective outcomes for patients.
• Greater Manchester Mental Health TrustcoreStrategic or Co-development PartnerNHS trust partner providing XR therapy treatment to patients across Greater Manchester area as part of mental health service delivery.
• Jackson HoggminorGTM or Marketing PartnerJackson Hogg partnered with XR Therapeutics as part of their corporate social responsibility programme, funding anxiety treatment for a child with autism. Partnership exemplifies employer-supported mental health intervention.
• Northern EchominorGTM or Marketing PartnerMedia coverage by Northern Echo of pioneering initiative using XR therapy to help young people on probation, providing visibility for the company's work in the justice sector.
• Percy Hedley FoundationminorStrategic or Co-development PartnerCharity partner receiving XR therapy services for beneficiaries with autism and related conditions.
• Toby Henderson TrustminorStrategic or Co-development PartnerCharity partner providing XR therapy treatment to children and young people with autism.
• Anxiety UKminorGTM or Marketing PartnerFeatured on Anxiety UK's 'And Breathe' podcast, hosted by David Smith, discussing XR therapy treatment with Penny from XR Therapeutics and Katheryn from Sheffield Children's NHS Foundation Trust.
• CHEATA (Centre for Healthcare Equipment and Technology Adoption)minorStrategic or Co-development PartnerNottingham University Hospitals NHS Trust division that conducted independent health economics evaluation of Boundless, modelling outcomes for GAD patients and demonstrating cost-effectiveness.

Scale indicators10 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• XRHealth: Israel/US-based VR therapy platform delivering clinician-supervised immersive treatment for anxiety, PTSD, phobias, and chronic pain. The most directly comparable peer: both companies sell therapist-controlled XR simulations combined with CBT-style protocols to health systems and providers.
• BehaVR: VR mental and behavioural health platform (formerly Oxford VR) building immersive therapies for anxiety, depression, chronic pain and stress. Closely aligned with XR Therapeutics on therapeutic modality (VR + CBT), target indications, and health-system go-to-market, with comparable therapist-led delivery model.
• Psious: VR therapy platform for mental health practitioners treating anxiety, phobias, OCD, and PTSD using controlled virtual environments. Direct peer because both companies market clinician-delivered, scene-based exposure therapy to therapists and clinics rather than direct-to-consumer entertainment VR.
• Ieso Digital Health: UK-based online CBT provider delivering therapist-led cognitive behavioural therapy to NHS IAPT services and private patients. Comparable on target customers (NHS talking therapies), treatment modality (CBT), and clinical outcomes focus, though delivered via text-based online therapy rather than immersive XR.

Broad incumbents

• Big Health: Digital therapeutics company behind Sleepio (insomnia) and Daylight (worry/anxiety), offering CBT-based digital treatments prescribed via health systems, payers, and employers. Comparable as a digital mental-health DTx competitor in adjacent anxiety indications, but operates without immersive VR hardware or scenes.
• Akili Interactive: Prescription digital therapeutic company (EndeavorRx, EndeavorOTC) with FDA-authorised cognitive treatment software. Comparable as a regulated SaMD digital therapeutics business targeting mental and cognitive health via clinicians, though focused on cognitive/ADHD rather than anxiety/phobia exposure therapy.
• SilverCloud Health (Amwell): Digital mental health platform acquired by Amwell, offering CBT-based programmes for anxiety and depression to NHS, employers and health plans. Comparable as a scaled digital CBT incumbent serving the same NHS talking therapies market, though via app/web rather than VR.

Emerging players

• Limbic: UK-based AI mental health platform supporting NHS talking therapies with patient-facing tools and therapist decision support. Comparable as a UK digital mental health company selling to NHS IAPT/talking therapies services, with overlapping customer base but a fundamentally different (AI/chat) modality.
• Mahana Therapeutics: Digital therapeutics company developing prescription CBT apps for conditions including IBS and mental health. Comparable as a regulated digital therapeutics competitor pursuing similar clinical evidence-led payer routes, although without immersive XR delivery.
• Oxford VR (legacy entity) / RealizedCare: Evolution of the original Oxford VR entity into RealizedCare, offering VR-based behavioural health interventions. Peer because of shared heritage in UK-academic VR mental health research and similar target markets, despite different current product focus and go-to-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/xr-therapeutics

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about XR Therapeutics